Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

News Daily News

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

March 01, 2022

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.